Souvenir, the CEO and founder of Souvie Biodelivery, responsibility's include strategic planning, technology development, and product commercialization. Souvenir founded Souvie Biodelivery in 2018 and since has raised $225k in grant funding.
Souvenir is an immunologist and research leader with over 25 years experience in academia. His areas of expertise include infectious disease, cell signaling, immunology, and cell biology. As a faculty member at Harvard Medical School, he directed NIH funded scientific projects that improved our understanding of the pathogenesis of HIV/AIDS. The engineered exosome platform stems from his observation that exosomes, which are natural shuttles used to maintain homeostasis, are exploited by HIV virus to exit its host and infect other cells.